10-K/A - Petros Pharmaceuticals, Inc. (0001815903) (Filer)

Fri, May 31, 9:08 PM (45 days ago)

Petros Pharmaceuticals, Inc. filed Amendment No. 1 to their Annual Report on Form 10-K for the fiscal year ending December 31, 2023. This amendment was filed to replace the consents of Marcum LLP and EisnerAmper LLP, the Company's current and former independent registered public accounting firms, respectively, to correctly reference the Company’s registration statements incorporating the financial statements from the original filing. There are no changes to the financial statements or other disclosures from the original Form 10-K. This amendment includes new certifications required by Sections 302 and 906 of the Sarbanes-Oxley Act but omits paragraphs 3, 4, and 5 of the certifications as no financial statements or disclosures related to internal controls are included. The amendment should be read in conjunction with the original Form 10-K filed on April 1, 2024.